Yes. It gets back to my commentary during my appearance here, that in fact the type of support we need is the one that's across that valley of death, more things like the IFIT program. That was a very small $100-million program. We had $2.2 billion in interest from the industry side, so $100 million doesn't go very far.
We had 65 projects. I think at least a third of them were bioenergy based. That also signals that a third of them were biochemicals, and another third were biomaterials.
So our agenda is not strictly bioenergy, and I don't think it should be.